Posted in | News | Green Building | Pollution | Water

Environmentally Friendly Surfactant-Enhanced In Situ Chemical Oxidation Method Remediates Contaminated Site

VeruTEK Technologies Inc. (OTCBB:VTKT), an international environmental technologies company, announced today that it has successfully completed an in-place remediation of contaminated soils and groundwater at a legacy site of a Fortune 500 client using its proprietary Surfactant-Enhanced In Situ Chemical Oxidation (S-ISCO™). This environmentally friendly, green and safe remedial approach allows a complete or near-complete remediation of subsurface soils and groundwater.

Contaminants at the site included chlorinated free phase or Dense Non Aqueous Phase Liquids (DNAPLs), trichloroethene (TCE), isomers of dichloroethene (DCE), and other chlorinated solvents. S-ISCOTM is a remediation process technology platform developed by VeruTEK® to target and remedy various types of DNAPLs.

VeruTEK's technology platforms, including S-ISCOTM, Surfactant Enhanced Product Recovery (SEPRTM), Green Synthesis of Nanometals and Nano Biopolymers and Coeluent Metal Extraction and Recovery, are effective and in-place technologies that use the chemistry of the soil with safe plant extracts and surfactants to remedy toxic pollution.

“VeruTEK® is a new type of environmental green technology company in a generally very low-tech market,” said John Collins, Ph.D., President and CEO of VeruTEK. “Existing simplistic and ineffective technologies (for example, digging, hauling and containment), in many cases, are not effective in protecting human health and the environment and in some cases may actually increase the risk to communities when implemented. These low-tech approaches frequently leave much of the contamination in place, because of partial removal of wastes, inaccessibility of wastes to be removed or stabilized because of buildings, roads, railroads and residences. So-called ‘stabilization’ of wastes inherently leaves the wastes in place and is only a partial and temporary solution. In contrast, we believe VeruTEK’s green technology successes can protect communities, reduce liability and reduce the costs of remediation for everyone.”

VeruTEK is one of the few commercial research and development companies in the world focused on remedying toxic compounds in the environment. The United States Environmental Protection Agency estimates there are 294,000 contaminated sites in the United States in need of remediation. Fortune 1000 companies have reserved between $250 billion and $1 trillion to clean up such sites, but many of these projects have been delayed due to a lack of effective cleanup technologies. As such, more than 50 percent of the remediation in the United States involves digging up soil and storing toxic waste in landfills. Technologies such as VeruTEK's remedy contaminants “in place”, providing a far better and more cost-effective solution.

VeruTEK maintains a state-of-the-art laboratory and research and development facility in Bloomfield, Connecticut. The company has developed remediation technologies to treat sources of soil and groundwater contamination at industrial, utility, commercial and government-owned sites. VeruTEK’s treatment processes enable controlled dissolution and desorption of organic phase chemical contaminants using plant-based, FDA-approved plant extracts along with simultaneous destruction of these toxic chemicals. The development of these technologies will eliminate the need for costly and unsustainable landfilling, as well as incineration of wastes formerly used at many sites. The company implements site-specific remedies with designer surfactant/oxidant combinations that are environmentally safe and non-intrusive to nearby communities.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.